Filter
768
Text search:
concentration
index
Featured
89
240
Language
Document type
451
139
95
32
19
19
8
2
1
1
1
Countries / Regions
50
37
26
19
19
16
16
15
13
13
13
13
12
12
12
12
11
10
9
8
8
7
7
7
6
6
6
6
6
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
345
93
51
33
27
15
6
Toolboxes
60
55
50
35
34
19
17
17
17
15
15
15
14
13
11
7
6
6
5
4
4
3
3
2
1
Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups
recommended
Treating children infected with intestinal worms is one of the simplest and most cost–effective ways to improve their health.
The recommendations are intended for a wide audience, including policy-makers and their expert advisers as well as technical and programme staff at government institution
...
Lignes directrices.
Collection Avis et Rapports.
A survival guide for clinicans.
3rd edition.
Prise en charge clinique des troubles mentaux,
neurologiques et liés à l'utilisation de substances
psychoactives dans les situations d'urgence humanitaire
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
Therapeutics Information and Pharmacovigilance Centre | TIPC
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
Guide for community-based management and care of people with dementia
Version 1.0
Mental Health and Substance Abuse
Division of NCD and Health through the Life-Course
World Health Organization Regional Office for the Western Pacific
SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
